Avidicure to Present Preclinical Data on TROP2-Targeting Antibody at ASCO 2025

Avidicure announced it will present preclinical data at the 2025 American Society of Clinical Oncology (ASCO) Annual Meeting. The data highlights AVC...
Home/KnloSights/Clinical Trial Updates/Avidicure to Present Preclinical Data on TROP2-Targeting Antibody at ASCO 2025